Aerpio Pharmaceuticals Inc (ARPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARPO | AZN | AMGN | GILD | BMY |
| Company | Aerpio Pharmaceuticals Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 2.22 | 198.85 | 350.23 | 136.18 | 59.15 |
| High | 2.30 | 198.99 | 350.23 | 136.34 | 59.22 |
| Low | 2.16 | 196.95 | 340.06 | 132.22 | 57.79 |
| Latest | 2.20 | 196.23 | 342.59 | 132.99 | 58.67 |
| Change | -0.02 | -4.46 | -7.57 | -2.88 | -0.46 |
| % Change | -0.90% | -2.22% | -2.16% | -2.12% | -0.78% |
| Volume | 826,000 | 441,265 | 379,237 | 1,067,922 | 1,754,538 |
| 20-Day Average Volume | 2,010,460 | 1,779,913 | 2,359,903 | 4,985,391 | 9,472,032 |
| Previous Close | 2.22 | 200.69 | 350.16 | 135.87 | 59.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.12 | 198.41 | 349.60 | 138.47 | 59.06 |
| 20-Day Raw Stochastic | 31.91% | 60.66% | 31.37% | 9.44% | 39.13% |
| 20-Day Relative Strength | 54.13 | 50.11 | 42.90 | 38.96 | 49.23 |
| Weighted Alpha | +30.52 | +40.07 | +20.22 | +25.10 | +26.06 |
| Today's Opinion | 100% Buy | 72% Buy | 24% Buy | 24% Buy | 48% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 56% Buy | 40% Buy | 64% Buy |
| Last Month's Opinion | 100% Buy | 40% Buy | 56% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.56% since 08/19/21 | -3.37% since 04/14/26 | -2.35% since 04/14/26 | -5.14% since 04/14/26 | +1.08% since 04/14/26 |
| Low | 2.07 on 08/20/21 | 197.01 on 04/21/26 | 340.48 on 04/21/26 | 132.22 on 04/21/26 | 57.22 on 04/15/26 |
| High | 2.30 on 08/26/21 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.96 on 04/15/26 | 60.48 on 04/17/26 |
| 1-Month | |||||
| %Chg | +3.77% since 07/26/21 | +7.57% since 03/20/26 | -1.46% since 03/20/26 | -2.90% since 03/20/26 | +2.14% since 03/20/26 |
| Low | 1.98 on 08/04/21 | 182.39 on 03/24/26 | 335.06 on 04/07/26 | 132.22 on 04/21/26 | 56.45 on 03/24/26 |
| High | 2.68 on 08/17/21 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +30.18% since 05/26/21 | +9.07% since 01/21/26 | -0.26% since 01/21/26 | +3.19% since 01/21/26 | +7.72% since 01/21/26 |
| Low | 1.62 on 06/29/21 | 180.34 on 01/22/26 | 335.06 on 04/07/26 | 129.00 on 01/22/26 | 54.21 on 01/29/26 |
| High | 3.32 on 07/08/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +23.60% since 02/26/21 | +18.66% since 10/21/25 | +13.80% since 10/21/25 | +7.38% since 10/21/25 | +31.81% since 10/21/25 |
| Low | 0.95 on 05/10/21 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 3.32 on 07/08/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 104,852 | 311,251,712 | 188,976,096 | 168,644,832 | 120,727,792 |
| Shares Outstanding, K | 47,660 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 15,000,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -4,320,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -4,410,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 1.69 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 11/09/21 | 04/29/26 | 04/30/26 | 05/07/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.36 | 16.26 | 16.89 | 9.78 |